US Stock MarketDetailed Quotes

VBIV VBI Vaccines

Watchlist

0.560
+0.020+3.67%

Close Jul 26 16:00 ET

0.560
0.0000.00%

Post 20:02 ET

16.06MMarket Cap-158P/E (TTM)

VBI Vaccines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

45.65%-11.77M

17.39%-60.88M

36.70%-12.06M

53.92%-7.96M

-10.09%-19.21M

-8.69%-21.66M

-84.66%-73.7M

-2.86%-19.05M

-328.64%-17.27M

-62.81%-17.45M

Net income from continuing operations

35.50%-17.9M

18.06%-92.84M

99.94%-13K

18.90%-20.44M

2.34%-44.63M

-30.57%-27.75M

-62.43%-113.3M

-12.55%-21.14M

-59.08%-25.21M

-161.50%-45.7M

Operating gains losses

-38.77%4.22M

-76.07%6.61M

-1,483.63%-15.28M

277.55%8.48M

-70.42%6.52M

60.46%6.9M

5,667.94%27.62M

---965K

--2.25M

19,404.42%22.04M

Depreciation and amortization

-2.95%493K

-3.44%1.99M

-8.85%474K

-5.32%498K

-5.90%510K

7.40%508K

12.32%2.06M

10.87%520K

18.20%526K

14.11%542K

Other non cash items

0.85%473K

31.94%475K

-71.77%35K

14.36%-501K

14.84%472K

14.39%469K

-81.36%360K

-45.85%124K

-354.35%-585K

70.54%411K

Change In working capital

92.74%-294K

-664.84%-10.05M

-56.58%132K

-142.46%-972K

-293.51%-5.16M

38.37%-4.05M

-107.83%-1.31M

119.12%304K

-73.24%2.29M

-8.32%2.67M

-Change in receivables

-28.65%-238K

213.79%99K

807.50%363K

-4,057.14%-277K

595.00%198K

-96.81%-185K

-226.09%-87K

37.93%40K

-87.27%7K

-147.06%-40K

-Change in inventory

-271.12%-2.22M

34.66%-3.72M

-34.11%-692K

73.08%-794K

-239.50%-1.63M

65.65%-599K

-1,009.16%-5.69M

-177.59%-516K

-379.51%-2.95M

-37.82%-481K

-Change in prepaid assets

673.73%677K

-5.56%17K

56.71%666K

-21.23%-1.29M

69.82%754K

-156.46%-118K

102.29%18K

-38.41%425K

31.61%-1.06M

207.51%444K

-Change in payables and accrued expense

178.31%2.51M

-174.80%-6.65M

-156.64%-729K

-103.12%-209K

-284.02%-2.51M

-598.04%-3.2M

2,398.03%8.89M

271.97%1.29M

218.04%6.7M

7,923.53%1.36M

-Change in other current assets

-106.17%-254K

472.65%5.79M

247.71%2.55M

-162.47%-1.23M

135.30%359K

625.80%4.12M

-125.71%-1.55M

-211.67%-1.72M

-17.13%1.97M

-173.06%-1.02M

-Change in other current liabilities

86.91%-533K

-310.41%-11.94M

-335.03%-1.89M

-54.01%-3.65M

-199.45%-2.33M

-10.35%-4.07M

-124.39%-2.91M

116.84%805K

-137.88%-2.37M

4.27%2.34M

-Change in other working capital

-2,209.09%-232K

39,625.00%6.36M

-821.43%-129K

58,918.18%6.47M

-92.31%4K

200.00%11K

104.88%16K

83.33%-14K

84.06%-11K

172.22%52K

Cash from discontinued investing activities

Operating cash flow

45.65%-11.77M

17.39%-60.88M

36.70%-12.06M

53.92%-7.96M

-10.09%-19.21M

-8.69%-21.66M

-84.66%-73.7M

-2.86%-19.05M

-328.64%-17.27M

-62.81%-17.45M

Investing cash flow

Cash flow from continuing investing activities

71.72%-151K

80.04%-867K

88.29%-170K

91.31%-113K

95.36%-50K

-3.69%-534K

-118.76%-4.34M

-138.03%-1.45M

-205.88%-1.3M

-104.35%-1.08M

Net PPE purchase and sale

71.72%-151K

80.04%-867K

88.29%-170K

91.31%-113K

95.36%-50K

-3.69%-534K

-117.74%-4.34M

-138.03%-1.45M

-205.88%-1.3M

-166.58%-1.08M

Cash from discontinued investing activities

Investing cash flow

71.72%-151K

80.04%-867K

88.29%-170K

91.31%-113K

95.36%-50K

-3.69%-534K

-118.76%-4.34M

-138.03%-1.45M

-205.88%-1.3M

-104.35%-1.08M

Financing cash flow

Cash flow from continuing financing activities

843K

16.71%22.7M

272K

15.38%22.43M

-56.09%19.45M

175.51%19.44M

Net issuance payments of debt

----

--0

----

66.67%20M

--0

----

Net common stock issuance

--868K

202,175.00%24.27M

2,941.67%365K

199,333.33%23.91M

--0

-99.96%12K

-99.60%12K

-100.17%-12K

--0

Net other financing activities

---25K

-179.75%-1.58M

---93K

----

48.30%-563K

--0

----

Cash from discontinued financing activities

Financing cash flow

--843K

16.71%22.7M

--272K

15.38%22.43M

--0

-56.09%19.45M

--0

175.51%19.44M

--0

Net cash flow

Beginning cash position

-62.18%23.69M

-48.54%62.63M

-57.57%35.45M

-74.71%20.84M

-60.14%40.39M

-48.54%62.63M

29.70%121.69M

-39.22%83.55M

-38.96%82.41M

-6.37%101.34M

Current changes in cash

50.08%-11.08M

33.35%-39.05M

41.68%-11.96M

1,563.15%14.35M

-3.96%-19.26M

-8.63%-22.19M

-312.74%-58.59M

-26.27%-20.5M

-66.81%863K

-169.26%-18.53M

Effect of exchange rate changes

74.47%-12K

122.74%108K

143.97%186K

-4.40%261K

26.26%-292K

-166.20%-47K

-244.82%-475K

-192.36%-423K

273.89%273K

-892.00%-396K

End cash Position

-68.82%12.6M

-62.18%23.69M

-57.57%35.45M

-74.71%20.84M

-60.14%40.39M

-48.54%62.63M

-39.22%83.55M

-38.96%82.41M

Free cash flow

46.28%-11.92M

20.87%-61.75M

40.35%-12.23M

56.54%-8.07M

-3.96%-19.26M

-8.56%-22.19M

-86.24%-78.04M

-7.17%-20.5M

-316.92%-18.57M

-66.58%-18.53M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	45.65%-11.77M	17.39%-60.88M	36.70%-12.06M	53.92%-7.96M	-10.09%-19.21M	-8.69%-21.66M	-84.66%-73.7M	-2.86%-19.05M	-328.64%-17.27M	-62.81%-17.45M
Net income from continuing operations	35.50%-17.9M	18.06%-92.84M	99.94%-13K	18.90%-20.44M	2.34%-44.63M	-30.57%-27.75M	-62.43%-113.3M	-12.55%-21.14M	-59.08%-25.21M	-161.50%-45.7M
Operating gains losses	-38.77%4.22M	-76.07%6.61M	-1,483.63%-15.28M	277.55%8.48M	-70.42%6.52M	60.46%6.9M	5,667.94%27.62M	---965K	--2.25M	19,404.42%22.04M
Depreciation and amortization	-2.95%493K	-3.44%1.99M	-8.85%474K	-5.32%498K	-5.90%510K	7.40%508K	12.32%2.06M	10.87%520K	18.20%526K	14.11%542K
Other non cash items	0.85%473K	31.94%475K	-71.77%35K	14.36%-501K	14.84%472K	14.39%469K	-81.36%360K	-45.85%124K	-354.35%-585K	70.54%411K
Change In working capital	92.74%-294K	-664.84%-10.05M	-56.58%132K	-142.46%-972K	-293.51%-5.16M	38.37%-4.05M	-107.83%-1.31M	119.12%304K	-73.24%2.29M	-8.32%2.67M
-Change in receivables	-28.65%-238K	213.79%99K	807.50%363K	-4,057.14%-277K	595.00%198K	-96.81%-185K	-226.09%-87K	37.93%40K	-87.27%7K	-147.06%-40K
-Change in inventory	-271.12%-2.22M	34.66%-3.72M	-34.11%-692K	73.08%-794K	-239.50%-1.63M	65.65%-599K	-1,009.16%-5.69M	-177.59%-516K	-379.51%-2.95M	-37.82%-481K
-Change in prepaid assets	673.73%677K	-5.56%17K	56.71%666K	-21.23%-1.29M	69.82%754K	-156.46%-118K	102.29%18K	-38.41%425K	31.61%-1.06M	207.51%444K
-Change in payables and accrued expense	178.31%2.51M	-174.80%-6.65M	-156.64%-729K	-103.12%-209K	-284.02%-2.51M	-598.04%-3.2M	2,398.03%8.89M	271.97%1.29M	218.04%6.7M	7,923.53%1.36M
-Change in other current assets	-106.17%-254K	472.65%5.79M	247.71%2.55M	-162.47%-1.23M	135.30%359K	625.80%4.12M	-125.71%-1.55M	-211.67%-1.72M	-17.13%1.97M	-173.06%-1.02M
-Change in other current liabilities	86.91%-533K	-310.41%-11.94M	-335.03%-1.89M	-54.01%-3.65M	-199.45%-2.33M	-10.35%-4.07M	-124.39%-2.91M	116.84%805K	-137.88%-2.37M	4.27%2.34M
-Change in other working capital	-2,209.09%-232K	39,625.00%6.36M	-821.43%-129K	58,918.18%6.47M	-92.31%4K	200.00%11K	104.88%16K	83.33%-14K	84.06%-11K	172.22%52K
Cash from discontinued investing activities
Operating cash flow	45.65%-11.77M	17.39%-60.88M	36.70%-12.06M	53.92%-7.96M	-10.09%-19.21M	-8.69%-21.66M	-84.66%-73.7M	-2.86%-19.05M	-328.64%-17.27M	-62.81%-17.45M
Investing cash flow
Cash flow from continuing investing activities	71.72%-151K	80.04%-867K	88.29%-170K	91.31%-113K	95.36%-50K	-3.69%-534K	-118.76%-4.34M	-138.03%-1.45M	-205.88%-1.3M	-104.35%-1.08M
Net PPE purchase and sale	71.72%-151K	80.04%-867K	88.29%-170K	91.31%-113K	95.36%-50K	-3.69%-534K	-117.74%-4.34M	-138.03%-1.45M	-205.88%-1.3M	-166.58%-1.08M
Cash from discontinued investing activities
Investing cash flow	71.72%-151K	80.04%-867K	88.29%-170K	91.31%-113K	95.36%-50K	-3.69%-534K	-118.76%-4.34M	-138.03%-1.45M	-205.88%-1.3M	-104.35%-1.08M
Financing cash flow
Cash flow from continuing financing activities	843K	16.71%22.7M	272K	15.38%22.43M	0	0	-56.09%19.45M	0	175.51%19.44M	0
Net issuance payments of debt	----	--0	--0	----	----	----	66.67%20M	--0	----	----
Net common stock issuance	--868K	202,175.00%24.27M	2,941.67%365K	199,333.33%23.91M	--0	--0	-99.96%12K	-99.60%12K	-100.17%-12K	--0
Net other financing activities	---25K	-179.75%-1.58M	---93K	----	----	----	48.30%-563K	--0	----	----
Cash from discontinued financing activities
Financing cash flow	--843K	16.71%22.7M	--272K	15.38%22.43M	--0	--0	-56.09%19.45M	--0	175.51%19.44M	--0
Net cash flow
Beginning cash position	-62.18%23.69M	-48.54%62.63M	-57.57%35.45M	-74.71%20.84M	-60.14%40.39M	-48.54%62.63M	29.70%121.69M	-39.22%83.55M	-38.96%82.41M	-6.37%101.34M
Current changes in cash	50.08%-11.08M	33.35%-39.05M	41.68%-11.96M	1,563.15%14.35M	-3.96%-19.26M	-8.63%-22.19M	-312.74%-58.59M	-26.27%-20.5M	-66.81%863K	-169.26%-18.53M
Effect of exchange rate changes	74.47%-12K	122.74%108K	143.97%186K	-4.40%261K	26.26%-292K	-166.20%-47K	-244.82%-475K	-192.36%-423K	273.89%273K	-892.00%-396K
End cash Position	-68.82%12.6M	-62.18%23.69M	-62.18%23.69M	-57.57%35.45M	-74.71%20.84M	-60.14%40.39M	-48.54%62.63M	-48.54%62.63M	-39.22%83.55M	-38.96%82.41M
Free cash flow	46.28%-11.92M	20.87%-61.75M	40.35%-12.23M	56.54%-8.07M	-3.96%-19.26M	-8.56%-22.19M	-86.24%-78.04M	-7.17%-20.5M	-316.92%-18.57M	-66.58%-18.53M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall